Cover Image

Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies

Saved in:

Bibliographic Details
Main Authors:	M. Nonnemacher (Author), W. Dampier (Author), M. Desimone (Author), V. Pirrone (Author), K. Kercher (Author), S. Passic (Author), J. Williams (Author), B. Wigdahl (Author)
Format:	Book
Published:	Elsevier, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Computational detection of off-target effects of CRISPR/Cas9-associated gRNAs
by: W. Dampier, et al.
Published: (2015)

PP 6.5 - 00205 Utilization of high-throughput assays and deep-learning for selection of CRISPR/Cas9-gRNA pairs used in an HIV-1 cure strategy
by: R. Berman, et al.
Published: (2022)

Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies
by: A. Allen, et al.
Published: (2017)

PP 1.43 - 00206 Evaluating integrated HIV-1 quasispecies using Near Full Length sequencing in ART-suppressed individuals in the Drexel CARES Cohort
by: M. Collins, et al.
Published: (2022)

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
by: Cheng-Han Chung, et al.
Published: (2020)

Broad-spectrum gRNAs abolish HIV-1 LTR-mediated transcription in cells that receive CRISPR/Cas9 therapy
by: B. Wigdahl, et al.
Published: (2019)

CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5' long terminal repeats to permanently inactivate latent provirus
by: B. Wigdahl, et al.
Published: (2019)

Targeting Hepatitis B Virus With CRISPR/Cas9
by: Christoph Seeger, et al.
Published: (2014)

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
by: Xiao-Hui Zhang, et al.
Published: (2015)

Genetic variation continues to occur in well-controlled HIV-1-infected patients
by: W. Dampier, et al.
Published: (2015)

Application of CRISPR/Cas9 in plant biology
by: Xuan Liu, et al.
Published: (2017)

CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017)

The CRISPR/Cas9 System Delivered by Extracellular Vesicles
by: Xinglong Zhu, et al.
Published: (2023)

Generation of desminopathy in rats using CRISPR‐Cas9
by: Henning T. Langer, et al.
Published: (2020)

One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
by: Maren Schiwon, et al.
Published: (2018)

Gene editing and therapy - A new tool: CRISPR/Cas9
by: Ashok M. Patil
Published: (2019)

Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors
by: Hong Wang, et al.
Published: (2018)

CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics
by: Fikre Birhanu Balcha, et al.
Published: (2023)

CRISPR/Cas9 systems: Delivery technologies and biomedical applications
by: Yimin Du, et al.
Published: (2023)

Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction
by: Emily Xia, et al.
Published: (2018)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
by: Wei-Jing Dai, et al.
Published: (2016)

In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
by: Matthew Behr, et al.
Published: (2021)

CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
by: Yaoyao Lu, et al.
Published: (2023)

Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems
by: Anna E. Caprifico, et al.
Published: (2022)

Novel Epigenetic Techniques Provided by the CRISPR/Cas9 System
by: Nina Xie, et al.
Published: (2018)

CRISPR/Cas9-mediated genome editing in nonhuman primates
by: Yu Kang, et al.
Published: (2019)

High-capacity adenovector delivery of forced CRISPR-Cas9 heterodimers fosters precise chromosomal deletions in human cells
by: Francesca Tasca, et al.
Published: (2023)

HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control
by: Chen Zhao, et al.
Published: (2018)

High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting
by: Amanda M. Ackermann, et al.
Published: (2017)

Inhibition of adenovirus replication by CRISPR-Cas9-mediated targeting of the viral E1A gene
by: Zrinka Didara, et al.
Published: (2023)

Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
by: Yvonne Knopp, et al.
Published: (2018)

Examining functional alterations of HIV-1 Tat variants associated with neurocognitively impaired patients in the Drexel Medicine CARES Cohort
by: M.R. Nonnemacher, et al.
Published: (2017)

Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment
by: Meng Lin, et al.
Published: (2023)

Genome-wide CRISPR/Cas9 screening for drug resistance in tumors
by: Zhongyan Zhang, et al.
Published: (2023)

VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
by: Claudia Montagna, et al.
Published: (2018)

Recent advances in CRISPR-Cas9-based genome insertion technologies
by: Xinwen Chen, et al.
Published: (2024)

Boosting CRISPR-Cas9 efficiency through enhanced homologous recombination
by: So Hyun Kim, et al.
Published: (2024)

Production of Knockout Mice using CRISPR/Cas9 in FVB Strain
by: Hee Sook Bae, et al.
Published: (2015)

Review, analysis, and optimization of the CRISPR Streptococcus pyogenes Cas9 system
by: Guohua Wang, et al.
Published: (2021)

CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell Therapy
by: Hyeseon Park, et al.
Published: (2024)